This is an AMP page which is for mobile devices.

View Non AMP page

Twitter

Link your Twitter Account to Market Wire News

When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.

Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / IONS - Ionis upgraded at BMO Capital Markets after data for lipid-lowering agent

IONS - Ionis upgraded at BMO Capital Markets after data for lipid-lowering agent

September, 03 2025 09:19 AM Ionis Pharmaceuticals Inc.

2025-09-03 09:19:11 ET

More on Ionis Pharmaceuticals

Positive CORE and CORE2 Topline Results
Ionis Pharmaceuticals, Inc. (IONS) Positive CORE And CORE2 Topline Results (Transcript)
Ionis: Dawnzera Approval Kicks Off New Era For Strikingly Undervalued Pharma
Ionis gains on late-stage trial win for hypertriglyceridemia therapy
Ionis gains FDA approval for RNA therapy donidalorsen for hereditary angioedema

For further details see:

Ionis upgraded at BMO Capital Markets after data for lipid-lowering agent

Stock Information

Company Name:	Ionis Pharmaceuticals Inc.
Stock Symbol:	IONS
Market:	NASDAQ
Website:	ionispharma.com

Get IONS Alerts

News, Short Squeeze, Breakout and More Instantly...

Market Wire News is a media platform, the information on this page was provided by SeekingAlpha via Quote Media. Read our full disclaimer.